In other countries
The same active substances on other registers, the same brand first.
- GUTRON 5 mg COMPRIMIDOSSpain · 5 mg · comprimido · Cheplapharm Arzneimittel GmbhSame form
- GutronItaly · Compressa · Istituto Luso Farmaco D'Italia S.P.A.Same form
- Gutron 5 mg, tablettenNetherlands · Tablet · Medcor Pharmaceuticals B.V.Same form
- Gutron 5 mg, tablettenNetherlands · Tablet · Euro Registratie Collectief B.V.Same form
- Gutron 5, tabletten 5 mgNetherlands · Tablet · CHEPLAPHARM Arzneimittel GmbHSame form
- Midodrine MedsurgeNew Zealand · Tab 5 mgSame form
- Midodrine MedsurgeNew Zealand · Tab 2.5 mgSame form
- Gutron Tab 2.5 MG TabSaudi Arabia · TAKEDA AUSTRIA GmbHSame form
- Jamp Midodrine Tablet 5 MGSingapore · 5mg · tablet · Goldplus Universal Pte LTDSame form
- Midodrine HydrochlorideUnited States · 10MG, 2.5MG, 5MG · tablet · Zydus LifesciencesSame form
- OrvatenUnited States · 10MG, 2.5MG, 5MG · tablet · Beijing YilingSame form
- ProamatineUnited States · 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Takeda Pharms USASame form
- GUTRON 2,5 mgRomania · 2,5mg · compr. · Takeda Austria GMBHSame substance
- GUTRON Injection*Saudi Arabia · TAKEDA AUSTRIA GmbHSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Midodrine
- Strength
- 2.5 MG
- Dosage form
- Tablet
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 3 Aug 2018
- Registration
- DIN 02473984
- Marketing authorisation holder
- Marcan Pharmaceuticals INC
- ATC code
- C01CA17
- Supply
- PRESCRIPTION